Education
About Us
Working with TipRanks
Follow Us
Virbac SA (FR:VIRP)
:VIRP
VIRP Stock Chart & Stats
Day’s Range― - ―
52-Week Range€249.70 - €400.00
Previous CloseN/A
Volume40.00
Average Volume (3M)4.92K
Market Cap
€2.57B
Enterprise ValueN/A
Total Cash (Recent Filing)€149.63M
Total Debt (Recent Filing)€307.01M
Price to Earnings (P/E)18.0
Beta0.65
Next Earnings
Sep 12, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 24, 2025Dividend Yield0.43%
Share Statistics
EPS (TTM)17.35
Shares Outstanding8,390,660
10 Day Avg. Volume4,576
30 Day Avg. Volume4,916
Financial Highlights & Ratios
PEG Ratio5.96
Price to Book (P/B)2.46
Price to Sales (P/S)0.00
P/FCF Ratio19.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€375.33Price Target Upside22.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Geographic PerformanceEurope and Latin America are exhibiting solid growth rates of around +8%, contributing positively to Virbac's overall performance.
Sales PerformanceVirbac's 1Q25 sales figures reached €375m, perfectly aligning with expectations and demonstrating organic growth of +4.9%.
Bears Say
Market ConditionsThe momentum in the USA and Asia remains soft, with only a +2.7% sales growth, indicating challenges in these markets.
Regional ChallengesAustralia is experiencing a significant decline with sales down by 15%, adversely affecting Virbac's performance in the Pacifique region.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.17%
Mutual Funds
― Other Institutional Investors
90.90% Public Companies and
Individual Investors
VIRP FAQ
What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest stock price was €249.70 and its highest was €400.00 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.57B.
When is Virbac SA’s upcoming earnings report date?
Virbac SA’s upcoming earnings report date is Sep 12, 2025 which is in 114 days.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Mar 13, 2025. The company reported €6.045 earnings per share for the quarter, beating the consensus estimate of N/A by €6.045.
Is Virbac SA overvalued?
According to Wall Street analysts Virbac SA’s price is currently Undervalued.
Does Virbac SA pay dividends?
Virbac SA pays a Annually dividend of €1.45 which represents an annual dividend yield of 0.43%. See more information on Virbac SA dividends here
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €6.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.328%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in FR:VIRP
---
Company Description
Virbac SA
Virbac SA is a global animal health company that develops, manufactures, and distributes a comprehensive range of products and services for veterinarians, livestock farmers, and pet owners. The company's offerings include vaccines, pharmaceuticals, and nutritional products for both companion animals and livestock, catering to the health and well-being of animals across various species.
---
VIRP Stock 12 Month Forecast
Average Price Target
€375.33
▲(22.26% Upside)
Technical Analysis
---